Medical News

RSS

NFCA and Partners Against Pain team up to create new Caregiver Cornerstones resource

The National Family Caregivers Association (NFCA) has teamed up with the national pain management education program, Partners Against Pain®, and advocate and author Lee Woodruff to create the new Caregiver Cornerstones resource.

6 Jan 2010

Sonova completes acquisition of Insound Medical, sees growth potential in Lyric brand of hearing systems

Sonova Holding AG, the world’s leading provider of hearing systems, announced today that it has successfully completed its acquisition of InSound Medical Inc., Newark, USA. InSound Medical developed the first extended wear hearing system which is placed deep in the ear canal and totally invisible from the outside, and markets it under the Lyric® brand.

6 Jan 2010

Biomet reports second quarter financial results for fiscal 2010

Biomet, Inc. net sales increased 8% during the second fiscal quarter ended November 30, 2009, to $695.6 million from $642.8 million during the second quarter of fiscal year 2009. On a constant currency basis, net sales increased 5% during the second quarter of fiscal 2010.

6 Jan 2010

Study indicates efficacy of antidepressants varies significantly depending on symptom severity

An analysis of randomized trials indicates that compared with placebo, the magnitude of benefit of antidepressant medications varies with the severity of depressive symptoms, and may provide little benefit for patients with mild or moderate depression, but appear to provide substantial benefit for patients with very severe depression, according to an article in the January 6 issue of JAMA.

6 Jan 2010

Lerner Medical Devices' Levia receives FDA clearance

Lerner Medical Devices, Inc. announced today that Levia®, a novel, in-home, ultraviolet B (UVB) phototherapy device, has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for treatment of psoriasis and certain other skin conditions such as vitiligo.

6 Jan 2010

Biotime ships six ACTCellerate progenitor cell lines to Millipore

BioTime, Inc. announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks.

6 Jan 2010

Health Canada approves Zyclara Cream for multiple actinic keratoses

Health Canada has approved Zyclara™ (imiquimod) Cream 3.75%, a topical prescription treatment for multiple actinic keratoses (AK) located on the face or balding scalp in adults. Actinic Keratosis is a common skin condition that can lead to squamous cell carcinoma, a form of non-melanoma skin cancer, if left untreated.

6 Jan 2010

Bioheart signs distribution agreements to market Home Heart Failure Monitoring Systems in U.S.

Bioheart, Inc. announced today that the company has signed distribution agreements with Restoration Medical, McRay Medical, Alamo Scientific and Morey Medical. These distributors will assist Bioheart with introducing its Home Heart Failure Monitoring Systems to physicians and hospitals throughout the United States.

6 Jan 2010

States that receive federal funds are more likely to implement obesity-prevention programs

States that received funding from two obesity prevention programs founded by the U.S. Centers for Disease Control & Prevention implemented more than twice as many obesity-prevention policy initiatives as states that did not receive funding, according to a study by researchers from RTI International.

6 Jan 2010

Excessive reduction of fat mass in girls may increase risk of osteoporosis in later life

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), fat mass is important in increasing bone size and thickness, but this effect appears to be stronger in girls than boys.

6 Jan 2010

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.

6 Jan 2010

Preclinical data of Geron's telomerase inhibitor drug published

Geron Corporation today announced the publication of preclinical data demonstrating that its telomerase inhibitor drug, imetelstat (GRN163L), inhibited telomerase activity and reduced tumor size in xenograft models of glioblastoma, and inhibited the activity of glioblastoma stem cells in culture.

6 Jan 2010

Ford transfers health care liabilities union trust

Dow Jones Newswires/The Wall Street Journal: "Ford Motor Co. said Monday it completed the transfer of its union retiree health-care liabilities to the United Auto Workers Retiree Medical Benefits Trust as part of a court-approved settlement agreement." The transfer "removed a substantial health care liability from the Detroit auto maker's balance sheet and significantly reduced its health care expenses."

6 Jan 2010

Health bills include proposals for new physician payment system

The health care overhaul bills on Capitol Hill do not upend traditional 'fee for service' payment for doctors, but they do include financial incentives for doctors to cut medical costs and improve patient care. Both the House and Senate bills include provisions to encourage the creation of accountable care organizations, or ACOs, as a way to test their viability.

6 Jan 2010

Multidisciplinary care, patient decision aids rarely offered by breast cancer surgeons

Most breast cancer surgeons' practices do not follow standards associated with the best quality of care, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

6 Jan 2010

Embrella Cardiovascular completes first clinical case using Embrella Embolic Deflector

Embrella Cardiovascular, Inc., a privately held company announced that it has completed its first clinical case using the Embrella Embolic Deflector™. The company has developed a novel technology designed to make less invasive cardiovascular procedures safer for patients by decreasing the risk of emboli traveling to the brain.

6 Jan 2010

Pixel and Panasonic Shikoku Electronics collaborate in the development of PixelOptics' electronic eyeglasses

PixelOptics, Inc. ("Pixel") of Roanoke, Virginia announced today that Pixel and Panasonic Shikoku Electronics Co., Ltd ("Panasonic Shikoku Electronics") of Matsuyama, Japan have been collaborating in the development of PixelOptics' electronic eyeglasses. Pixel, the world's first composite ophthalmic lens company, is developing, and plans to market and sell both static (fixed focus) and electronic dynamic (changeable focus) lenses. Pixel launched atLast!® its first static composite enhanced multifocal in November of 2008. Panasonic Shikoku Electronics is one of group companies of Panasonic Corporation. Panasonic Corporation is a global electronics company and is well known around the world.

From PHC Europe B.V. 6 Jan 2010

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Researchers have identified two cellular proteins that are important factors in hepatitis C virus infection, a finding that may result in the approval of new and less toxic treatments for the disease, which can lead to liver cancer and cirrhosis.

6 Jan 2010

Cancer Research UK and CRT to undertake phase I clinical trial of DI-B4

CANCER RESEARCH UK and Cancer Research Technology (CRT), the charity's development and commercialisation arm, are to undertake a phase I clinical trial of an investigational monoclonal antibody1 drug from Merck KGaA, Darmstadt, Germany, called DI-B4 - it is announced today (Monday).

6 Jan 2010

Most of world's 13m preterm births occur in Africa, Asia

The "vast majority" of the world's 13 million preterm births each year occur in developing countries where the babies' "chances of survivals are low," according to an article published Monday in the January issue of the Bulletin of the World Health Organization, Reuters reports.

6 Jan 2010

Medical News

NFCA and Partners Against Pain team up to create new Caregiver Cornerstones resource

Sonova completes acquisition of Insound Medical, sees growth potential in Lyric brand of hearing systems

Biomet reports second quarter financial results for fiscal 2010

Study indicates efficacy of antidepressants varies significantly depending on symptom severity

Lerner Medical Devices' Levia receives FDA clearance

Biotime ships six ACTCellerate progenitor cell lines to Millipore

Health Canada approves Zyclara Cream for multiple actinic keratoses

Bioheart signs distribution agreements to market Home Heart Failure Monitoring Systems in U.S.

States that receive federal funds are more likely to implement obesity-prevention programs

Excessive reduction of fat mass in girls may increase risk of osteoporosis in later life

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

Preclinical data of Geron's telomerase inhibitor drug published

Ford transfers health care liabilities union trust

Health bills include proposals for new physician payment system

Multidisciplinary care, patient decision aids rarely offered by breast cancer surgeons

Embrella Cardiovascular completes first clinical case using Embrella Embolic Deflector

Pixel and Panasonic Shikoku Electronics collaborate in the development of PixelOptics' electronic eyeglasses

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Cancer Research UK and CRT to undertake phase I clinical trial of DI-B4

Most of world's 13m preterm births occur in Africa, Asia

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News